Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling

Debanjan Dhar; Laura Antonucci; Hayato Nakagawa; Ju Youn Kim; Elisabeth Glitzner; Stefano Caruso; Shabnam Shalapour; Ling Yang; Mark A. Valasek; Sooyeon Lee; Kerstin Minnich; Ekihiro Seki; Jan Tuckermann; Maria Sibilia; Jessica Zucman‐Rossi; Michael Karin

doi:10.1016/j.ccell.2018.05.003

Related publications

Article2020

Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance

Sander P.J. Joosten, Marcel Spaargaren, Hans Clevers, Steven T. Pals

Article2019

MET Signaling Overcomes Epidermal Growth Factor Receptor Inhibition in Normal and Colorectal Cancer Stem Cells Causing Drug Resistance

Sander P.J. Joosten, Tomohiro Mizutani, Marcel Spaargaren, Hans Clevers, Steven T. Pals

Article2016

Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling

Jaclyn Quin, Keefe T. Chan, Jennifer R. Devlin, Donald P. Cameron, Jeannine Diesch, Carleen Cullinane, Jessica Ahern, Amit Khot, Nadine Hein, Amee J. George, Katherine M. Hannan, Gretchen Poortinga, Karen E. Sheppard, Kum Kum Khanna, Ricky W. Johnstone, Denis Drygin, Grant A. McArthur, Richard B. Pearson, Elaine Sanij, Ross D. Hannan

Article2008

Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells

Ilio Vitale, Laura Senovilla, Lorenzo Galluzzi, Alfredo Criollo, Sonia Vivet, Maria Castedo, Guido Guido Kroemer

Article2014

Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition

Atsushi Umemura, Eek Joong Park, Koji Taniguchi, Jun Hee Lee, Shabnam Shalapour, Mark A. Valasek, Mariam Aghajan, Hayato Nakagawa, Ekihiro Seki, Michael N. Hall, Michael Karin